Dr. Albert D'hulst
ActiveDr. Albert D'hulst has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30k and a net result of €28k. Its solvency ranks better than 51% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
91
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency90
Growth-
Track record67
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity ample (current ratio 2.8; short-term debt: 35.4% and cash: 97.5% of total assets), and 35.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
64.6%
Return on assets
60.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
31 d early
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€30k
Total assets
€47k
Net result
€28k
Working capital
€30k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €47k
Equity
€30k
Debt
€17k
Debt finances 35.4% of the balance-sheet total.
Key figures and ratios
EBITDA
€36k
Cash flow
€29k
Solvency
64.6%
Current ratio
2.80
Quick ratio
2.80
Debt / equity
0.55
ROE
93.4%
ROA
60.3%
Interest coverage
180.75
Debt
€17k
Debt ≤ 1 year
€17k
Income taxes
€7k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€47k
Formation expenses20€301
Current assets29/58€47k
Amounts receivable within one year40/41€606
Other amounts receivable41€606
Cash at bank and in hand54/58€46k
Deferred charges and accrued income490/1€274
Equity and liabilities
Total equity and liabilities10/49€47k
Equity10/15€30k
Contributions10/11€2k
Reserves13€28k
Distributable reserves133€28k
Amounts payable17/49€17k
Amounts payable within one year42/48€17k
Taxes, remuneration and social security45€240
Taxes450/3€240
Other amounts payable47/48€16k
Income statement
Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€243
Gross operating margin9900€36k
Operating profit (loss)9901€36k
Financial charges65/66B€198
Recurring financial charges65€198
Profit (loss) for the period before taxes9903€35k
Income taxes67/77€7k
Profit (loss) for the period9904€28k
Profit (loss) for the period to be appropriated9905€28k
Appropriation of the result
Profit (loss) to be appropriated9906€28k
Transfer to equity691/2€28k
To other reserves6921€28k
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2025
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waelhemstraat 321030 SchaarbeekGround area
94 m²
Building footprint
83 m²
Volume, LiDAR
1,233 m³
Parcel 21902A0407/00E002, Brussels · tallest building 18.6 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Albert D'hulst
since 20252.370.322.088
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21902A0407/00E002 | Brussels | 94 m² | 1 · 83 m² | 18.6 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9845003C2D3953B9BC30
Similar companies · same sector, comparable size
S.H. Respiratory Medicine
BE 0746.533.378
Sint-Genesius-Rode · Eq €30k
Bongiorno-Ghilain
BE 0692.807.553
Kraainem · Eq €30k
Cabinet d'Ophtalmologie Dr Jans
BE 1028.354.804
Mons · Eq €30k
ORL.Dr.P .LEFEBVRE
BE 0844.157.148
Chaudfontaine · Eq €30k
DR BORN CARDIOLOGIE
BE 0768.986.108
Seraing · Eq €30k
Of 16,621 companies in sector 86220 we hold annual accounts for 7,972. 4,006 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-02-2025
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.